NAUT - NASDAQ
Nautilus Biotechnology, Inc.
$2.58
-3.7%Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.
At a Glance
Live SnapshotNautilus Biotechnology, Inc. Management Team
Ms. Anna Mowry
Chief Financial Officer & Treasurer
Compensation
$519,212
Mr. Kentaro Suzuki
Chief Marketing Officer
Compensation
$143,435
Ms. Gwen E. Weld
Chief People Officer
Compensation
$390,968
Mr. Sujal M. Patel
Co-Founder, Chief Executive Officer, President, Secretary & Director
Compensation
$536,200
Dr. Parag Mallick Ph.D.
Co-Founder, Chief Scientist & Director
Compensation
$420,000
Mr. Matthew B. Murphy ESQ.
General Counsel
Compensation
$382,645
Dr. Subra Sankar Ph.D.
Senior Vice President of Product Development
Compensation
$38,473
Nautilus Biotechnology, Inc. Insider Positioning
During the last 12 months, insiders have purchased $376K worth of NAUT shares, with no selling activity reported.
3 Months
0
0.00
0
0.00
+0
+$0
3-6 Months
25.0K
65.24K
0
0.00
+65K
+$65K
6-9 Months
87.5K
62.99K
0
0.00
+63K
+$63K
9-12 Months
361.5K
247.80K
0
0.00
+248K
+$248K
Top Buyers
Patel Sujal M
Director, 10 Percent Owner, Officer: Ceo, President, And Secretary
$201K
Mcilwain Matthew S
Director
$31K
Nazem Farzad
Director
$31K
Epperly Melissa B,
Director
$31K
Posard Matthew L.
Director
$31K
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $376K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Insider Participation
5 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
SEC Filings
NAUT - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | June 17, 2026 | 2026 | |
DEF 14A DEF 14A 2024 N/A | April 29, 2025 | December 31, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | April 26, 2024 | December 31, 2023 | 2023 | |
DEF 14A DEF 14A 2023 N/A | April 27, 2023 | June 14, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | April 28, 2022 | June 14, 2022 | 2022 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.